Abstract
Today fibrin sealing is an accepted method in operative medicine, known all over the world, and there are still new indications emerging for it. The ultimate method of fibrin sealing has certainly not yet been determined, and there are many questions regarding its efficacy (and the improvement of its efficacy), its quality (which is decisive for an undelayed healing process), and its safety (i.e., exclusion of the transmission of viral infections). For these reasons research is still being carried on, and new experiences are to be expected in the future, in particular in terms of wound healing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Spängier HP, Braun F, Holle J, Moritz E, Wolner E (1976) Die lokale Anwendung von Fibrinogen und Kollagen zur Blutstillung in der Herzchirurgie. Wien Med Wochenschr 126:86–89
Haverich A, Borst HG (1980) Fibrin glue for treatment of bleeding in cardiac surgery. In: Bircks W, Ostermeyer J, Schulte HD (eds) Cardiovascular surgery 1980. Springer, Berlin Heidelberg New York, pp 621–624
Borst HG (1981) Replacement of ascending aorta and aortic valve. Ann Thorac Surg 32:613–615
Borst HG, Haverich A, Walterbusch G, Maatz W (1982) Fibrin adhesive: an important hemostatic adjunct in cardiovascular operations. J Thorac Cardiovasc Surg 84:548–553
Haverich A, Walterbusch G, Borst HG (1981) The use of fibrin glue for sealing vascular prosthesis of high porosity. Thorac Cardiovasc Surg 29:252–254
Haverich A, Maatz W, Walterbusch G (1982) Evaluation of fibrin seal in animal experiments. Thorac Cardiovasc Surg 30:215–222
Walterbusch G, Haverich A, Borst HG (1982) Clinical experience with fibrin glue for local bleeding control and sealing of vascular prostheses. Thorac Cardiovasc Surg 30:234–235
Haverich A, Wahlers T, Walterbusch G, Borst HG (1986) The use of fibrin sealant and fibrin sealant combined with antibiotics in cardiovascular surgery. In: Schlag G, Redl H (eds) Fibrin sealant in operative medicine, vol 5. Thoracic surgery, cardiovascular surgery. Springer, Berlin Heidelberg New York, pp 185–190
Huth C, Seybold-Epting W, Hoffmeister HE (1983) Local hemostasis with fibrin glue after intracardiac repair of tetralogy of Fallot and transposition of the great arteries. Thorac Cardiovasc Surg 31:142–146
Huth C, Hoffmeister HE (1986) Use of fibrin glue (Tissucol/Tisseel) to achieve hemostasis in patches and suture lines in surgical repair of congenital heart defects. In: Schlag G, Redl H (eds) Fibrin sealant in operative medicine, vol 5. Thoracic surgery, cardiovascular surgery. Springer, Berlin Heidelberg New York, pp 164–175
Rousou J, Levitsky S, Gonzalez-Lavin L, Cosgrove D, Magilligan D, Weldon C, Hiebert C, Hess P, Joyce L, Bergland J, Gazzaniga A (1988) Randomized clinical trial of Tisseel — two-component fibrin sealant in cardiac surgery patients undergoing resternotomy or reoperation — a multicenter study. Symposium on Tisseel — two-component fibrin sealant in cardiothoracic surgey, 18 April 1988, Los Angeles
Gasser G, Mossig H, Fischer M, Eidler R, Kläring W, Lurf H (1983) Modifikation der suprapubischen Prostatektomie unter Verwendung eines biologischen Klebeverfahrens. Wien Klin Wochenschr 95:399–403
Vecsey D (1980) Über eine neue Methode der Blutstillung mit Klebematerial bei der Adenomektomie. Z Urol Nephrol 1:57–62
Vecsey D (1988) Prevention of early complications associated with the operation of bladder neck adenoma (prostatic hyperplasia). Orv Hetil 129:871–876
Guttmann J (1979) Untersuchung eines Fibrinklebers für die Anwendung in der Chirurgie peripherer Nerven. Dissertation, Technical University of Vienna
Seelich T, Redl H (1980) Theoretische Grundlagen des Fibrinklebers. In: Schimpf K (ed) Fibrinogen, Fibrin und Fibrinkleber. Schattauer, Stuttgart, pp 199–208
Redl H, Stanek G, Hirschl A, Schlag G (1982) Fibrinkleber-Antibiotika-Gemische — Festigkeit und Elutionsverhalten. In: Cotta H, Braun A (eds) Fibrinkleber in Orthopädie und Traumatologie. Thieme, Stuttgart, pp 18–21
Redl H, Schlag G, Stanek G, Hirschl A, Seelich T (1983) In vitro properties of mixtures of fibrin seal and antibiotics. Biomaterials 4:29–32
Duckert F, Nyman D, Gastpar H (1978) Factor XIII fibrin and collagen. Coll platelet interact. Schattauer, Stuttgart, pp 391–396
Bäumer F, Bader A, Keller F, Henrich HA (1988) Flüssigkeits- und Eiweißbilanz bei III.-gradigen Verbrennungen. In: Zellner PR (ed) Fibrinklebung in der Verbrennungschirurgie — Plastischen Chirurgie. Springer, Berlin Heidelberg New York, pp 31–36
Eckersley JRT, Dudley HAF (1988) Wounds and wound healing. Br Med Bull 44:423–436
Wokalek H (1988) Cellular events in wound healing. CRC Crit Rev Biocompatibil 4:209–246
Brown LF, van de Water L, Harvey VS, Dvorak HF (1988) Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma. Am J Pathol 130:455–465
Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM (1987) Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 57:673–686
Peacock EE (1984) Inflammation and the cellular response to injury. In: Wound repair, 3rd edn. Saunders, Philadelphia, pp 1–14
Knighton DR, Hunt TK, Scheuenstuhl H, Halliday B, Werb Z, Banda M (1983) Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 221:1283–1285
Diegelmann RF, Kim JC, Lindblad WJ, Smith TC, Harris TM, Cohen IK (1987) Collection of leukocytes, fibroblasts, and collagen within an implantable reservoir tube during tissue repair. J Leukocyte Biol 42:667–672
Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS (1986) Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037–1050
Sporn MB, Roberts AB, Wakefield LM, Assoian RK (1986) Transforming growth factor beta: biological function and chemical structure. Science 233:532–534
Brändstedt S, Olson PS (1980) Effect of defibrinogenation on wound strength and collagen formation. A study in the rabbit. Acta Chir Scand 146:483–486
Brändstedt S, Olson PS (1981) Lack of influence on collagen accumulation in granulation tissue with delayed defibrinogenation. A study in the rabbit. Acta Chir Scand 147:89–91
Brändstedt S, Olson PS, Ahonen J (1980) Effect of defibrinogenation on collagen synthesis in granulation tissue. A study in the rabbit. Acta Chir Scand 146:551–553
Brändstedt S, Rank F, Olson PS (1980) Wound healing and formation of granulation tissue in normal and defibrinogenated rabbits. An experimental model and histological study. Eur Surg Res 12:12–21
Brändstedt S, Rank F, Olson PS, Ahonen J (1980) Cell composition of granulation tissue in defibrinogenated rabbits. Acta Chir Scand 146:545–549
Köstering H, Nagel GA (1980) Prophylaxe und Therapie von Zytostatika-Hautnekrosen. Onkologie 3:3–6
Wieding JU, Merten HA, Köstering H (1987) Applikation von Fibrinogen und Fibrin bei Störungen der primären Wundheilung. Med Welt 38:581–587
Bäumer F, Bader A, Henrich HA, Buchmann F (1987) Zum Stellenwert der Applikation von Fibrinkleber bei der chirurgischen Behandlung ausgedehnter Wundflächen. Med Welt 38:1258–1261
Grabosch A, Fisseler-Eckhoff A (1988) Fibrinklebung zur Versorgung von Brandwunden — Klinische und histologische Untersuchungen. In: Zellner PR (ed) Fibrinklebung in der Verbrennungschirurgie — Plastischen Chirurgie. Springer, Berlin Heidelberg New York, pp 31–36
Fisseler-Eckhoff A, Grabosch A, Donati I, Müller KM (1988) Histologische Untersuchungsergebnisse nach Hauttransplantation mit und ohne Fibrinkleber. Ellipse 15:180–186
Schlag G, Redl H, Turnher M, Dinges HP (1986) The importance of fibrin in wound repair. In: Schlag G, Redl H (eds) Fibrin sealant in operative medicine, vol 2. Ophthalmology, neurosurgery. Springer, Berlin Heidelberg New York, pp 3–12
Beck E, Duckert F, Vogel A, Ernst M (1962) Der Einfluß des fibrinstabilisierenden Faktors (FSF) auf Funktion und Morphologie von Fibroblasten in vitro. Z Zellforsch Mikrosk Anat 57:327–346
Bruhn HD, Christophers E, Pohl J, Schoel G (1979) Regulation der Fibroblastenproliferation durch Fibrinogen/Fibrin, kälteunlösliches Globulin und Faktor XIII. Blut 38:65
Turowski G, Schaadt M, Bartheis M, Diehl V, Poliwode H (1979) Unterschiedlicher Einfluß von Fibrinogen und Faktor XIII auf das Wachstum von Primär- und Kulturfibroblasten. Blut 38:65
Blümel G, Ascherl R, Geissdörfer K, Schäfer G (1988) Experimentelle Untersuchungen zur Fibrinklebung bei Verbrennungswunden. In: Zellner PR (ed) Fibrinklebung in der Verbrennungschirurgie — Plastischen Chirurgie. Springer, Berlin Heidelberg New York, pp 25–30
Henrich HA, Bäumer F, Oberschelp J, Kilian K (1988) Einfluß von drei verschiedenen Gewebeklebern auf Vollhauttransplantate bei Verbrennungen. Med Welt 39:701–706
Ferry JD, Morrison PR (1947) Preparation and properties of serum and plasma proteins. VIII. The conversion of human fibrinogen to fibrin under various conditions. J Am Chem Soc 69:388–400
Redl H, Schlag G, Dinges HP (1985) Vergleich zweier Fibrinkleber. Einfluß ionischer Zusätze auf Fibrinstruktur sowie Morphologie und Wachstum menschlicher Fibroblasten. Med Welt 36:769–776
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Lambrecht JT, Klinger M (1988) Resorption von Fibrinkleber durch isolierte Knochenzellen in der Kultur. Med Welt 39:493–496
Harmand MF, Michel D, Bagot d’Arc M (1986) Effects of fibrin seals on human fibroblast attachment and multiplication. In: Proceedings of European congress on biomaterials, Bologna
Seelich T (1988) A propos des critères de qualité d’une colle biologique. Lyon Chir 84:259–260
Burnouf-Radosevich M, Duval P, Burnouf T, Huart JJ (1988) Composition protéique et qualité de colles biologiques européennes. Lyon Chir 84:191–195
Scheele J, Schricker KT, Goy D, Lampe I, Panis R (1981) Hepatitisrisiko der Fibrinklebung in der Allgemeinchirurgie. Med Welt 32:783–788
Panis R, Scheele J (1981) Hepatitisrisiko bei der Fibrinklebung in der HNO-Chirurgie. Laryngol Rhinol Otol 60:367–368
Eder G, Neumann M, Cerwenka R, Baumgarten K (1986) Preliminary results of a randomized controlled study on the risk of hepatitis transmission of a two-component fibrin sealant (Tissucol/Tisseel). In: Schlag G, Redl H (eds) Fibrin sealant in operative medicine, vol 2. Ophthalmology, neurosurgery. Springer, Berlin Heidelberg New York, pp 51–59
Grasgrove D (1988) Tissel-Two-Component Fibrin Sealant in Reoperative Cardiovascular Surgery — The Cleveland Clinic Experience. Symposium as Tissel — Two component fibrin sealant in cardiothoracic surgery, 18 April 1988, Los Angeles
Petricciani JC, McDougal JS, Evatt BL (1985) Case for concluding that heat-treated licenced anti-haemophilic factor is free from HTLV-III. Lancet ii:890–891
Dinges HP, Redl H, Thurnher M, Schießer A, Schlag G (1986) Morphometric studies on wound healing after systemic administration of adriamycin and local application of fibrin sealant. Application of a new wound healing model using spongiosa implants. Pathol Res Pract 181:746–754
Redl H, Schlag G (1986) Properties of different tissue sealants with special emphasis of fibrinogen-based preparations. In: Schlag G, Redl H (eds) Fibrin sealant in operative medicine. Springer, Berlin Heidelberg New York, pp 27–38
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schlag, G., Redl, H. (1989). Fibrin Sealant: Efficacy, Quality, and Safety. In: Waclawiczek, HW. (eds) Progress in Fibrin Sealing. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48362-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-48362-2_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50797-0
Online ISBN: 978-3-642-48362-2
eBook Packages: Springer Book Archive